SEC EDGAR CompanyFacts fact · reporting period
SPERO THERAPEUTICS, INC.: revenue
One fact, its scope and the complete path back to the official record.
Reported value
$66.802M{"amount": 66802000, "concept": "us-gaap:Revenues", "currency": "USD"}- Entity
- SPERO THERAPEUTICS, INC.
- Metric
- revenue
- Period
- 2025-01-01 – 2025-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T14:25:43.967634+02:00
Raw response SHA-256
7d8d28a786cc1f9d14a78b641809cfb8…Official-identifier path
https://factanker.com/fact/sec/cik-0001701108/revenue/2025-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 12586000, "concept": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "currency": "USD"} (evidence 0001193125-26-126192)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.